Natixis Advisors L.P. boosted its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 11.9% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,630 shares of the medical equipment provider’s stock after acquiring an additional 1,881 shares during the quarter. Natixis Advisors L.P.’s holdings in Align Technology were worth $5,891,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of ALGN. Raymond James Trust N.A. raised its position in Align Technology by 39.4% during the 1st quarter. Raymond James Trust N.A. now owns 934 shares of the medical equipment provider’s stock valued at $407,000 after purchasing an additional 264 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Align Technology by 11.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 180,978 shares of the medical equipment provider’s stock valued at $78,911,000 after purchasing an additional 18,153 shares in the last quarter. Prudential PLC bought a new stake in Align Technology during the 1st quarter valued at $955,000. Cetera Investment Advisers raised its position in Align Technology by 4.9% during the 1st quarter. Cetera Investment Advisers now owns 1,713 shares of the medical equipment provider’s stock valued at $747,000 after purchasing an additional 80 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its position in Align Technology by 17.1% during the 1st quarter. Sequoia Financial Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $229,000 after purchasing an additional 77 shares in the last quarter. Hedge funds and other institutional investors own 87.07% of the company’s stock.
Align Technology Price Performance
Shares of NASDAQ:ALGN opened at $370.86 on Thursday. The business’s 50-day moving average is $352.51 and its 200 day moving average is $329.03. Align Technology, Inc. has a 1 year low of $172.05 and a 1 year high of $413.20. The firm has a market capitalization of $28.38 billion, a P/E ratio of 91.12, a P/E/G ratio of 2.84 and a beta of 1.63.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on ALGN shares. HSBC started coverage on Align Technology in a research report on Wednesday. They set a “buy” rating for the company. Stifel Nicolaus boosted their price target on Align Technology from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Thursday, August 24th. Piper Sandler boosted their price target on Align Technology from $370.00 to $415.00 in a research report on Thursday, July 27th. StockNews.com started coverage on Align Technology in a research report on Thursday, August 17th. They issued a “buy” rating for the company. Finally, Jefferies Financial Group boosted their price target on Align Technology from $367.00 to $400.00 in a research report on Thursday, July 27th. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $371.63.
Get Our Latest Stock Analysis on Align Technology
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services).
Recommended Stories
- Five stocks we like better than Align Technology
- 3 Tickers Leading a Meme Stock Revival
- Why Ambarella’s 20% Decline is a Strong Signal for New Investment
- 3 REITs to Buy and Hold for the Long Term
- Why Analysts Love These 2 Car Sales Platforms, And Avoid Dealers
- What Are the U.K. Market Holidays? How to Invest and Trade
- A Significant Reversal is in Sight for These 5 Med Tech Companies
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
